Results 151 to 160 of about 4,442 (181)

Immunogenicity, Pathogenesis, and Host's Immuno-Responses to Marburg Virus Infection. [PDF]

Pathogens
Siddig EE, Ndembi N, Ahmed A, Muvunyi CM.   +3 more
europepmc   +1 more source

Correction: Immunogenicity of differentially glycosylated Marburg virus glycoproteins expressed in mammalian and insect cells. [PDF]

Virol J
Li J, Wang S, Cui Y, Song L, Song Z, Huang P, Chi X, Fang T, Dong Y, Li R, Fan P, Wang Y, Bi L, Li J, Zhang G, Yu C.   +15 more
europepmc   +1 more source

Marburg Virus Disease: Pathophysiology, Diagnostic Challenges, and Global Health Preparedness Strategies. [PDF]

Ann Glob Health
Francis DL, Reddy SSP, Logaranjani A, Sai Karthikeyan SS, Rathi M.   +4 more
europepmc   +1 more source

A single-shot ChAd3-MARV vaccine confers rapid and durable protection against Marburg virus in nonhuman primates

Science Translational Medicine, 2022
Marburg virus (MARV) causes a severe hemorrhagic fever disease in primates with mortality rates in humans of up to 90%. MARV has been identified as a category A bioterrorism agent by the Centers for Disease Control and Prevention (CDC) and priority pathogen A by the National Institute of Allergy and Infectious Diseases (NIAID), needing urgent research ...
Ruth Hunegnaw, Anna N. Honko, Lingshu Wang, Derick Carr, Tamar Murray, Wei Shi, Lam Nguyen, Nadia Storm, Caitlyn N M Dulan, Kathryn E. Foulds, Krystle N. Agans, Robert W. Cross, Joan B. Geisbert, Cheng Cheng, Aurélie Ploquin, Daphne A. Stanley, Thomas W. Geisbert, Gary J. Nabel, Nancy J. Sullivan   +18 more
openalex   +3 more sources

Sexual transmission of recently re-emerged deadly Marburg virus (MARV) needs explorative studies and due attention for its prevention and feasible spread – Correspondence

International Journal of Surgery, 2022
Sandip Chakraborty, Deepak Chandran, Ranjan K. Mohapatra, Ali A. Rabaan, Saad Alhumaid, Abbas Al Mutair, Chiranjib Chakraborty, Harapan Harapan, Kuldeep Dhama   +8 more
openalex   +3 more sources

Les filovirus : Marburg (MARV) et Ebola (EBOV : Ebola Virus)

, 2023
Hervé Fleury
openalex   +2 more sources

Postexposure vaccination with a recombinant virus vector prevents Marburg virus (MARV) disease in primates,

Inpharma Weekly, 2006
&NA;
openalex   +2 more sources